Prognostic factors and therapy assessment of IgA nephropathy: Report from a single unit in Iran

Renal Failure

Volumn 33, Issue 6, 2011, Pages 572-577

  Soleymanian, Tayebeh ^a   Najafi, Iraj ^a   Salimi, Bahare Haji ^a   Broomand, Behrooz ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

ESRD; IgA nephropathy; prognostic factors; proteinuria; treatment

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PREDNISONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IRAN; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BIOPSY; CREATININE; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, IGA; GLUCOCORTICOIDS; HUMANS; INCIDENCE; IRAN; KIDNEY FAILURE, CHRONIC; KIDNEY GLOMERULUS; MALE; MIDDLE AGED; PREDNISONE; PROGNOSIS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79958777482     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2011.585001     Document Type: Article

References (46)

1. D'Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med. 1987;64:709-727. (Pubitemid 18047151)
2. Schena FP. A retrospective analysis of the natural history of primary IgA nephropathy worldwide. Am J Med. 1990;89:209-215. (Pubitemid 20254446)
3. Coppo R, Amore A, Hogg R, Emancipator S. Idiopathic nephropathy with IgA deposits. Pediatr Nephrol. 2000;15:139-150.
4. Clarksson AR, Woodroffe AJ, Aarons I. IgA nephropathy in patients followed-up for at least ten years. Semin Nephrol. 1987;7:377-378.
5. D'Amico G, Colasanti G, di Belgioioso GB, et al. Long term follow up of IgA mesangial nephropathy: Clinico-histological study in 374 patients. Semin Nephrol. 1987;7:355-358.
6. Johnston PA, Brown JS, Braumholtz DA, Davison AM. Clinicopathological correlations and long-term follow-up of 253 United Kingdom patients with IgA nephropathy. A report from the MRC Glomerulonephritis Registry. Q J Med. 1992;84:619-627. (Pubitemid 23007764)
7. Ygame M, Suzuki D, Jiade K, et al. Value of pathological grading in prediction of renal survival in IgA nephropathy. Nephrology. 1996;2:107-117. (Pubitemid 126442351)
8. D'Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol. 2004;24:179-196. (Pubitemid 38685989)
9. Beukhof JR, Kardaun O, Schaafsma W, et al. Toward individual prognosis of IgA nephropathy. Kidney Int. 1986;29:549-556. (Pubitemid 16129066)
10. Manno C, Giovanni F, Strippoli M, Torres D, Rossini M, Schena FP. A novel simpler histological classification for renal survival in IgA nephropathy: A retrospective study. Am J Kid Dis. 2007;49:763-775. (Pubitemid 46802935)
11. Julian BA, Waldo FB, Rifai A, Mestecky J. IgA nephropathy, the most common glomerulonephritis world-wide: A neglected disease in the United States? Am J Med. 1988;84:129-132.
12. Nicholls KM, Fairly KF, Dowling JP, Kincaid-Smith P. The clinical course of mesangial IgA associated nephropathy in adults. Q J Med. 1984;53:22-50.
13. D'Amico G, Minetti L, Ponticelli G, et al. Prognostic indicators in idiopathic IgA mesangial nephropathy. Q J Med. 1986;59:363-378. (Pubitemid 16099605)
14. Woo KT, Edmondson RPS, Wu AYT, et al. The natural history of IgA nephritis in Singapore. Clin Nephrol. 1986;25:15-21. (Pubitemid 16187266)
15. Kusumoto Y, Takebayashi S, Taguchi T, Harada T, Naito S. Long-term prognosis and prognostic indices of IgA nephropathy in juvenile and adult Japanese. Clin Nephrol. 1987;28:118-124. (Pubitemid 17139034)
16. Velo M, Lozano L, Egido J, Gutierrez-Millet V, Hernando L. Natural history of IgA nephropathy in patients followed up for more than ten years in Spain. Semin Nephrol. 1987;7:346-350.
17. Bogenschutz O, Bohle A, Batz C, et al. IgA nephritis: On the importance of morphological and clinical parameters in the long-term prognosis of 239 patients. Am J Nephrol. 1990;10:137-147. (Pubitemid 20170283)
18. Rekola S, Bergstrand A, Buch H. IgA nephropathy. Development of hypertension in IgA nephropathy as a marker of poor prognosis. Am J Nephrol. 1990;10:290-295. (Pubitemid 20317740)
19. Alamartine E, Sabatier JC, Guerin C, Berliet JM, Berthoux F. Prognostic factors in mesangial IgA glomerulonephritis: An extensive study with univariate and multivariate analyses. Am J Kidney Dis. 1991;18:12-19.
20. Ibels LS, Gyory AZ. IgA nephropathy: Analysis of the natural history, important factors in the progression of renal disease, and a review of the literature. Medicine. 1994;73:79-109.
21. Li T, Ho L, Szeto C, Yu LyMee, Lai M-M. Prognostic indicators of IgA nephropathy in the Chinese-clinical and pathological perspectives. Nephrol Dial Transplant. 2002;17:64-69. (Pubitemid 34093011)
22. D'Amico G. Influence of clinical and histological features on actuarial renal survival in adult patients with idiopathic IgA nephropathy, membranous nephropathy, and membranoproliferative glomerulonephritis: Survey of the recent literature. Am J Kidney Dis. 1992;20:315.
23. Szeto CC, Lai F, To KF, et al. The natural history of immunoglobulin A nephropathy among patients with hematuria and minimal proteinuria. Am J Med. 2001;110:434.
24. D'Amico G. Natural history of idiopathic IgA nephropathy: Role of clinical and histological prognostic factors. Am J Kidney Dis. 2000;36:227.
25. Rekola S, Bergstrand A, Bucht H. Deterioration of GFR in IgA nephropathy as measured by 51Cr-EDTA clearance. Kidney Int. 1991;40:1050.
26. Nozawa R, Suzuki J, Takahashi A, et al. Clinicopathological features and the prognosis of IgA nephropathy in Japanese children on long-term observation. Clin Nephrol. 2005;64:171.
27. Lau KK, Gaber LW, Delos Santos NM, Fisher KA, Grimes SJ, Wyatt RJ. Pediatric IgA nephropathy: Clinical features at presentation and outcome for African-Americans and Caucasians. Clin Nephrol. 2004;62:167.
28. Bartosik LP, Lajoie G, Sugar L, Cattran DC. Predicting progression in IgA nephropathy. Am J Kidney Dis. 2001;38:728.
29. Hall CL, Bradley R, Kerr A, Attoti R, Peat D. Clinical value of renal biopsy in patients with asymptomatic microscopic hematuria with and without low-grade proteinuria. Clin Nephrol. 2004;62:267.
30. Ikee R, Kobayashi S, Saigusa T, et al. Impact of hypertension and hypertension-related vascular lesions in IgA nephropathy. Hypertens Res. 2006;29:15.
31. Donadio JV, Bergstralh EJ, Grande JP, Rademcher DM. Proteinuria patterns and their association with subsequent endstage renal disease in IgA nephropathy. Nephrol Dial Transplant. 2002;17:1197.
32. Reich HN, Troyanov S, Scholey JW, Cattran DC. Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol. 2007;18:3177.
33. Haas M. Histologic subclassification of IgA nephropathy: A clinicopathologic study of 244 cases. Am J Kidney Dis. 1997;29:829.
34. Lee HS, Lee MS, Lee SM, et al. Histological grading of IgA nephropathy predicting renal outcome: Revisiting H. S. Lee's glomerular grading system. Nephrol Dial Transplant. 2005;20:342.
35. Geddes CC, Rauta V, Gronhagen-Riska C, et al. A tricontinental view of IgA nephropathy. Nephrol Dial Transplant. 2003;18:1541.
36. Radford MG, Donadio JV, Bergstralh EJ, Grande JP. Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol. 1997;8:199-207. (Pubitemid 127455874)
37. Schena FP. Immunoglobulin A nephropathy with mild renal lesions: A call in the forest for physicians and nephrologists. Am J Med. 2001;110:499-500.
38. Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: A long-term follow up of 204 cases in China. Nephrology. 2008;13:242-246. (Pubitemid 351341460)
39. Kobayashi Y, Hiki Y, Fujii K, Kurokawa A, Tateno S. Moderately proteinuric IgA nephropathy: Prognostic prediction of individual clinical courses and steroid therapy in progressive cases. Nephron. 1989;53:250.
40. Kobayashi Y, Hiki Y, Kokubo T, Horii A, Tateno S. Steroid therapy during the early stage of progressive IgA nephropathy. A 10-year follow-up study. Nephron. 1996;72:237.
41. Pozzi C, Bolasco PG, Fogazzi GB, et al. Corticosteroids in IgA nephropathy: A randomised controlled trial. Lancet. 1999;353:883.
42. Pozzi C, Andrulli S, Del Vecchio L, Melis P. Corticosteroid effectiveness in IgA nephropathy: Long-term results of a randomized, controlled trial. J Am Soc Nephrol. 2004;15:157.
43. Tamura S, Ueki K, Ideura H, et al. Corticosteroid therapy in patients with IgA nephropathy and impaired renal function. Clin Nephrol. 2001;55:192.
44. Moriyama T, Honda K, Nitta K, Yumura W, Nihei H. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function. Clin Exp Nephrol. 2004;8:237.
45. Lv J, Zhang H, Chen Y, et al. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: A randomized controlled trial. Am J Kidney Dis. 2009;53:26.
46. Manno C, Torres DD, Rossini M, Pesce F, Schena FP. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy. Nephrol Dial Transplant. 2009;24:3694.